Search results for "Retrospective"

showing 10 items of 3553 documents

Idiopathische makuläre Teleangiektasie (IMT) – Verlaufsbeobachtung mit und ohne Laserphotokoagulation

2010

Purpose The aim of this study was to evaluate the effectiveness of laser photocoagulation for idiopathic macular telangiectasia (IMT) by using the revised and simplified classification of Yannuzzi 2006. Patients and methods The Yannuzzi classification was used for a retrospective analysis of the medical records of all patients with idiopathic macular telangiectasia as diagnosed consecutively in the University Eye Clinic of Mainz in the time period from 1 / 02 to 12 / 06. Laser treatment was indicated only in those eyes which presented with a visual acuity below 10 / 20 (follow-up interval in median 37 months, minimum 13 months). Results 12 patients with unilateral macular telangiectasia (IM…

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryLaser treatmentTreatment outcomeFollow up studiesMacular oedemamedicine.diseaseeye diseasesSurgeryOphthalmologyRetrospective analysisMedicinesense organsmedicine.symptombusinessMacular telangiectasiaKlinische Monatsblätter für Augenheilkunde
researchProduct

Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study

2021

BACKGROUND The anti-tumour necrosis factor (TNF)-α adalimumab is the only licenced biologic for moderate-to-severe hidradenitis suppurativa (HS). No predictors of response have been identified so far. OBJECTIVES To identify clinical parameters predicting response to adalimumab and confirm its efficacy/safety. METHODS The data of 389 patients with HS treated with adalimumab in 21 Italian centres were reviewed. Sex, age at onset/diagnosis/baseline, body mass index, smoking, phenotype, previous treatments, concomitant antibiotics and 'therapeutic delay', defined as the time from HS onset to adalimumab initiation, were assessed. Response to adalimumab and its impact on quality of life (QoL) wer…

medicine.medical_specialtyVisual analogue scaleAnti-Inflammatory AgentsDermatologySeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSettore MED/35Quality of lifeInternal medicineSeverity of illnessmedicineAdalimumabHumansHidradenitis suppurativahidrosadenitis suppurativaRetrospective Studiesbusiness.industryAdalimumabRetrospective cohort studyOdds ratioDermatology Life Quality Indexmedicine.diseasehumanitiesHidradenitis SuppurativaTreatment OutcomeQuality of LifeAdalimumab Hidradenitis Suppurativa quality of lifeSettore MED/35 - MALATTIE CUTANEE E VENEREEbusinessmedicine.drug
researchProduct

The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization

2020

Summary Background/introduction Vesicoureteral reflux (VUR) potentially leads to renal damage, scarring, and eventually end-stage renal disease. Endoscopic treatment is well tolerated in children, it has reduced costs, and it effectively prevents urinary tract infections (UTIs), while avoiding long term antibiotics use. Objective With the aim to investigate the time needed to reach the stabilization of the dextranomer/hyaluronic acid (Dx/HA) implants and to identify cut-off heights to ensure the success of the procedure, the authors analyzed ultrasonographic (US) intra-operative appearance of the mounds following endoscopic treatment for VUR and repeated the measurements during serial posto…

medicine.medical_specialtyVoiding cystourethrogramUrologyUrinary system030232 urology & nephrologyVesicoureteral reflux03 medical and health sciences0302 clinical medicine030225 pediatricsmedicineHumansHyaluronic AcidAntibiotic prophylaxisChildMound heightRetrospective StudiesVesico-Ureteral Refluxmedicine.diagnostic_testReabsorptionbusiness.industryVesicoureteral refluxRefluxInfantDextransmedicine.diseaseSurgeryTreatment OutcomeReabsorptionSub-ureteral injectionPediatrics Perinatology and Child HealthDextranomerImplantbusinessmedicine.drugJournal of Pediatric Urology
researchProduct

Implant-specific follow-up imaging of treated intracranial aneurysms: TOF-MRA vs. metal artifact reduced intravenous flat panel computed tomography a…

2017

Aim To compare the diagnostic quality of time-of-flight magnetic resonance angiography (TOF-MRA) and metal-artefact-reduction (MAR) flat-panel-detector computed tomography angiography (FPCTA) and to determine the imaging technique best suited for evaluation endovascular and surgically treated aneurysms. Methods The image quality of TOF-MRA and MAR-FPCTA of 44 intracranial implants (coiling: n= 20; clipping: n= 15; coiling + stenting: n= 9) in a patient cohort of 25 was evaluated by two independent readers. Images obtained using MAR-FPCTA (20 second scan time, 496 projections, intravenous contrast medium administration; Artis Zee, Siemens Healthcare, Forchheim) were compared with TOF-MRA-ima…

medicine.medical_specialtyWilcoxon signed-rank testImage qualityComputed Tomography Angiographymedicine.medical_treatmentContrast MediaMagnetic resonance angiography030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAneurysmMcNemar's testmedicineImage Processing Computer-AssistedHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesComputed tomography angiographyRetrospective Studiesmedicine.diagnostic_testbusiness.industryIntracranial AneurysmGeneral MedicineClipping (medicine)Prostheses and Implantsmedicine.diseaseImage EnhancementSurgical InstrumentsCerebral AngiographyMetalscardiovascular systemStentsImplantRadiologybusinessArtifacts030217 neurology & neurosurgeryMagnetic Resonance AngiographyFollow-Up StudiesClinical radiology
researchProduct

Recurrence quantification analysis as a tool for complex fractionated atrial electrogram discrimination

2012

International audience; Atrial fibrillation is the most encountered pathology of the heart rate. The reasons of its occurrence and its particular characteristics remain unknown, resulting from complex phenomena interaction. From these interactions emerges Complex Fractionated Atrial Electrograms (CFAE) which are useful for the ablation procedure. This study presents a method based on nonlinear data analysis, the Recurrence Quantification Analysis (RQA) applied on intracardiac atrial electrograms to detect CFAE particularities. The results obtained on areas previously tagged by a cardilogist show a good sensitivity to CFAE. Combination of RQA features offers a larger discrimination potential…

medicine.medical_specialty[ INFO.INFO-TS ] Computer Science [cs]/Signal and Image Processing[ NLIN.NLIN-CD ] Nonlinear Sciences [physics]/Chaotic Dynamics [nlin.CD]0206 medical engineeringTreatment outcome[ SPI.SIGNAL ] Engineering Sciences [physics]/Signal and Image processing02 engineering and technology030204 cardiovascular system & hematologySensitivity and SpecificityIntracardiac injection03 medical and health sciences0302 clinical medicine[INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineAtrial FibrillationmedicineHumansDiagnosis Computer-AssistedRetrospective Studiesmedicine.diagnostic_testbusiness.industryBody Surface Potential MappingReproducibility of ResultsAtrial fibrillation[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease020601 biomedical engineeringTreatment OutcomeSurgery Computer-AssistedRecurrence quantification analysis[NLIN.NLIN-CD]Nonlinear Sciences [physics]/Chaotic Dynamics [nlin.CD]Cardiologybusiness[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processingElectrocardiographyAlgorithms2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society
researchProduct

Embolization with ethylene vinyl alcohol copolymer (Onyx®) for peripheral hemostatic and non-hemostatic applications: a feasibility and safety study

2018

International audience; Background: Onyx® is a liquid embolic agent, which is approved for the treatment of cerebral vascular lesions but still rarely used in peripheral interventional radiology. The goal of this study is to report the feasibility and safety of embolization with Onyx® for peripheral hemostatic and non-hemostatic endovascular procedures.Methods: Retrospective study of all consecutive patients who underwent visceral or peripheral embolization with Onyx® for hemostatic or non-hemostatic purpose in our department between May 2014 and November 2016. Demographic data, clinical presentation, underlying etiology, culprit vessel, endovascular procedure, pain during embolization, out…

medicine.medical_specialty[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatmentTranscatheter embolization030204 cardiovascular system & hematologyVialCulprit030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicineRadiology Nuclear Medicine and imagingEmbolizationTranscatheter embolizationmedicine.diagnostic_testbusiness.industryportal vein systemRetrospective cohort studyInterventional radiologyperipheral vascular lesions3. Good healthPeripheralSurgeryEtiologyhemorrhagebusinessethylene vinyl alcohol (EVOH) copolymer
researchProduct

Diamond-Shaped Mini-Craniotomy: A New Concept in Neurosurgery

2021

Abstract Background We describe, step by step, a modified, less invasive, diamond-shaped mini-craniotomy that optimizes dural opening and can be performed in elderly patients affected by acute subdural or intracerebral hematomas, in therapy with antiplatelets or anticoagulants. Methods We retrospectively analyzed the clinical records of 67 patients (mean age of 78.5 years) treated in our institution, during a period of 10 years, with this novel diamond-shaped craniotomy. Seventeen patients were treated for intracerebral hemorrhage and 50 patients for acute subdural hematomas. All the patients were in therapy with antiplatelets or anticoagulants. Results Approach-related complications were n…

medicine.medical_specialtyanticoagulantsmedicine.medical_treatmentNeurosurgeryTemporal muscleelderlyacute subdural hematomaAtrophymedicineDeformityHematoma Subdural AcuteHumansGlasgow Coma ScaleCraniotomyAgedCerebral HemorrhageRetrospective StudiesIntracerebral hemorrhagePalsybusiness.industrycraniotomymedicine.diseaseintracerebral hemorrhageSurgerybody regionsTreatment Outcomemedicine.anatomical_structureScalpSurgeryNeurology (clinical)Neurosurgerymedicine.symptombusiness
researchProduct

Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

2021

Aging with multimorbidity and polytherapy are the most significant factors that could led to inappropriate prescribing of contraindicated medications in patients with chronic kidney disease (CKD). The aim of this study was to evaluate the prescriptions of contraindicated drugs in older adults in CKD and to identify their associated factors in a hospital context. An observational retrospective study was carried out considering all patients ≥65 years with at least one serum creatinine value recorded into the REPOSI register into 2010–2016 period. The estimated glomerular filtration rate (eGFR) was applied to identify CKD. A descriptive analysis was performed to compare demographic and clinica…

medicine.medical_specialtyappropriateness of prescriptionprescribing patternsRenal functionContext (language use)RM1-950Logistic regressionNOchemistry.chemical_compoundolder patientInternal medicinehospital settingmedicinePharmacology (medical)LS4_4Medical prescriptionprescribing patternappropriateness of prescriptions chronic kidney disease hospital setting older patients prescribing patterns real-world data.Original ResearchPharmacologyCreatininereal-world databusiness.industryRetrospective cohort studymedicine.diseaseolder patientsreal-world data.appropriateness of prescriptions; chronic kidney disease; hospital setting; older patients; prescribing patterns; real-world dataappropriateness of prescriptionschemistryObservational studyTherapeutics. Pharmacologybusinesschronic kidney diseaseKidney diseaseFrontiers in Pharmacology
researchProduct

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwi…

2016

Background: Interleukin (IL)-1 inhibitors have been suggested as possible therapeutic options in a large number of old and new clinical entities characterized by an IL-1 driven pathogenesis. Objectives: To perform a nationwide snapshot of the on-label and off-label use of anakinra (ANA) and canakinumab (CAN) for different conditions both in children and adults. Methods: We retrospectively collected demographic, clinical, and therapeutic data from both adult and pediatric patients treated with IL-1 inhibitors from January 2008 to July 2016. Results: Five hundred and twenty-six treatment courses given to 475 patients (195 males, 280 females; 111 children and 364 adults) were evaluated. ANA wa…

medicine.medical_specialtyautoinflammatory disorders treatment interleukin (IL)-1 anakinra canakinumabDoseanakinra; autoinflammatory disorders; canakinumab; interleukin (IL)-1; treatmentautoinflammatory disorders; treatment; interleukin (IL)-1; anakinra; canakinumab030204 cardiovascular system & hematologyOff-label usecanakinumab03 medical and health sciencesSettore MED/38 - Pediatria Generale E Specialistica0302 clinical medicineInternal medicinemedicinePharmacology (medical)Interleukin-1 inhibitorsAdverse effectOriginal Research030203 arthritis & rheumatologyPharmacologyAnakinratreatmentbusiness.industrylcsh:RM1-950Anakinra; Autoinflammatory disorders; Canakinumab; Interleukin (IL)-1; Treatment; Pharmacology; Pharmacology (medical)InterleukinRetrospective cohort studySurgeryinterleukin (IL)-1Canakinumablcsh:Therapeutics. PharmacologyAutoinflammatory disorderSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAautoinflammatory disordersAntirheumatic drugsbusinessmedicine.druganakinra
researchProduct

Disease control and treatment pathways of asthma patients after initiating ICS/LABA

2019

Introduction: GINA guidelines recommend medium dose (MED) and high dose (HD) ICS/LABA as the preferred controller for step 4 asthma patients and clinicians should consider step up/down based on their patients’ asthma control. Limited data is available on how step 4 patients respond to ICS/LABA and how they step up/down in clinical practice. Methods: We conducted a retrospective cohort study using UK Clinical Practice Research Datalink to assess control status of asthma patients in one year after initiating a MED or HD ICS/LABA between 2007 and 2015, and examined their treatment pathways within one year after the treatment initiation. Results: 29,229 and 16, 575 patients initiated MED and HD…

medicine.medical_specialtybiologyExacerbationbusiness.industryOffice visitsRetrospective cohort studyLamamedicine.diseasebiology.organism_classificationDisease controlMedication possession ratioInternal medicineIcs labamedicinebusinesshormones hormone substitutes and hormone antagonistsAsthmaAirway pharmacology and treatment
researchProduct